Soleus Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$49.6M	Sell	902,304 -177,000	-16%	-$9.73M	3.28%	8
2025 Q1	$76.3M	Buy	1,079,304 +77,904	+8%	+$5.51M	5.49%	4
2024 Q4	$65.8M	Buy	+1,001,400	New	+$65.8M	4.14%	3
2023 Q3	–	Sell	-57,800	Closed	-$5.01M	–	97
2023 Q2	$5.01M	Buy	+57,800	New	+$5.01M	0.56%	49